All PharmGKB pathways
PharmGKB · ClinPGx

Oxcarbazepine Pathway, Pharmacokinetics

PA166246121 Last updated June 2021 Caroline F. Thorn
2/5
Drugs & chemicals
2
Genes
0/0
Conditions
18
Reactions
Oxcarbazepine Pathway, Pharmacokinetics pathway diagram
Oxcarbazepine Pathway, Pharmacokinetics — pathway diagram from PharmGKB / ClinPGx
Click to enlarge

About this pathway

Background

Oxcarbazepine is a second generation antiepileptic drug with similarities to carbamazepine but developed to be less metabolized by CYP enzymes and therefore considered less likely to have drug-drug interactions [Article:25063510]. However, similar to carbamezpine, there is an increased risk of severe cutaneous adverse reactions. The CPIC Dosing Guideline for oxcarbazepine recommends an alternative drug for oxcarbazepine-naive patients carrying at least one copy of HLA-B*15:02 due to the association of this allele with an increased risk of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). The FDA label states that oxcarbazepine should be avoided in patients positive for HLA-B*1502.

Metabolism

Oxcarbazepine is reduced by cytosolic reductases AKR1C1, AKR1C2, AKR1C3, AKR1C4, CBR1 and CBR3 to the active metabolite 10-monohydroxy oxcarbazepine also called liscarbazepine, monohydroxy derivative or MHD [Article:25063510]. MHD has two stereoisomers, AKR1C3, AKR1C4 preferentialy form R-MHD whereas AKR1C1, AKR1C2, CBR1 and CBR3 predominantly form S-MHD [Article:25063510].

A third generation antiepileptic and prodrug form of S-MHD, eslicarbazpine acetate is also depicted above [Article:32049739]. Eslicarbazpine acetate is metabolized by arylacetamide deacetylase, AADAC into MHD [Article:33446525].

The majority of MHD is glucuronidated and excreted into urine [Article:25063510]. A small proportion of MHD, less than 4% of parent drug, is oxidized to form the inactive dihydroxy derivative dihydroxycarbazepine (also called carbamazepine diol) [Article:25063510].

Transport

Oxcarbazepine and MHD are substrates of ABCB1 [Article:28528287]. Polymorphisms in ABCC2 are associated with oxcarbazepine dose suggesting it is also involved in oxcarbazepine transport [Article:25823783].

Reactions & interactions (18)

  • Biochemical Reaction
    10-monohydroxy oxcarbazepine dihydroxycarbazepine
  • Biochemical Reaction
    eslicarbazepine 10-monohydroxy oxcarbazepine
  • Biochemical Reaction
    oxcarbazepine 10-monohydroxy oxcarbazepine
  • Biochemical Reaction
    10-monohydroxy oxcarbazepine oxcarbazepine glucuronide
  • Catalysis
    AADAC Biochemical Reaction
  • Catalysis
    ABCC2 Transport
  • Catalysis
    ABCB1 Transport
  • Catalysis
    AKR1C3 Biochemical Reaction
  • Catalysis
    CBR1 Biochemical Reaction
  • Catalysis
    CBR3 Biochemical Reaction
  • Catalysis
    AKR1C4 Biochemical Reaction
  • Catalysis
    AKR1C1 Biochemical Reaction
  • Catalysis
    AKR1C2 Biochemical Reaction
  • Catalysis
    ABCB1 Transport
  • Catalysis
    UGT2B7 Biochemical Reaction
  • Catalysis
    UGT1A9 Biochemical Reaction
  • Transport
    oxcarbazepine oxcarbazepine
  • Transport
    10-monohydroxy oxcarbazepine 10-monohydroxy oxcarbazepine

Edit history (1)

  • 2021-06-28 Create
Oxcarbazepine Pathway, Pharmacokinetics pathway diagram (enlarged)